Journal of Cardiac Failure
Volume 13, Issue 4 , Pages 241-246, May 2007

Remote Active Monitoring in Patients With Heart Failure (RAPID-RF): Design and Rationale

  • Leslie A. Saxon, MD

      Affiliations

    • From the University of Southern California, Los Angeles, California
    • Corresponding Author InformationReprint requests: Leslie A. Saxon, MD, 1500 San Pablo Street, Second Floor, Los Angeles, CA 90033.
    • ,
  • John P. Boehmer, MD

      Affiliations

    • Hershey Medical Center, Hershey, Pennsylvania
    • ,
  • Stacey Neuman, PhD

      Affiliations

    • Boston Scientific Corporation, St. Paul, Minnesota
    • ,
  • Christopher M. Mullin, MS

      Affiliations

    • The Integra Group, Brooklyn Park, Minnesota

Received 19 October 2006; received in revised form 11 December 2006; accepted 19 December 2006.

Los Angeles, California; Hershey, Pennsylvania; St. Paul, Minnesota; Brooklyn Park, Minnesota

Abstract 

Background

Heart failure (HF) ambulatory disease management programs appear to offer the greatest benefit to HF patients at highest risk, defined as having New York Heart Association (NYHA) functional Class III or IV symptoms. The Latitude Patient Management System is the first HF management tool to use wireless telemetry present in a cardiac resynchronization therapy defibrillator (CRT-D) device that is linked to remotely collect blood pressure and weight measures, permitting a single transmission reporting device data. Potential advantages of this system include ease of data transmissions, correlation among measures of HF status, arrhythmic events, and device performance. However, the use and ultimate utility of these combined features for patient management are untested.

Methods and Results

The Remote Active Monitoring in Patients with Heart Failure (RAPID-RF) study is a multicenter registry that will enroll up to 1000 patients on the Latitude Patient Management System from approximately 100 centers. The primary objective is to examine physician responses to Latitude Active Monitoring data alerts by assessing alert-related medical interventions. Minimum follow-up will be 3 months after implant with a maximum follow-up time of 24 months after implant.

Conclusions

The RAPID-RF study will provide important preliminary data on how remotely collected HF and arrhythmic surveillance data alter the management of HF patients with CRT-D devices.

Key Words: Remote monitoring, heart failure, cardioverter resynchronization therapy, defibrillator

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 All decisions regarding this manuscript were made by a guest editor.Sponsored in full by Boston Scientific Corporation. This trial is registered on www.clinicaltrials.gov (trial identifier: NCT00334451).Leslie A. Saxon is a paid consultant to Boston Scientific Corporation and Medtronic. John P. Boehmer is a paid consultant to Boston Scientific Corporation. Christopher M. Mullin is a paid consultant to Boston Scientific Corporation.

PII: S1071-9164(06)01296-6

doi:10.1016/j.cardfail.2006.12.004

Journal of Cardiac Failure
Volume 13, Issue 4 , Pages 241-246, May 2007

Article Tools

* Image Usage & Resolution